Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Aug 2;4(8):e2121310.
doi: 10.1001/jamanetworkopen.2021.21310.

Short-term Reactions Among Pregnant and Lactating Individuals in the First Wave of the COVID-19 Vaccine Rollout

Alisa Kachikis  1 , Janet A Englund  2 , Michael Singleton  3 , Isabela Covelli  4 , Alison L Drake  5 , Linda O Eckert  1   5
Affiliations
Observational Study

Short-term Reactions Among Pregnant and Lactating Individuals in the First Wave of the COVID-19 Vaccine Rollout

Alisa Kachikis et al. JAMA Netw Open. .

Abstract

This cohort study investigates short-term reactions associated with COVID-19 vaccines among pregnant and lactating individuals vs individuals neither pregnant nor lactating but planning pregnancy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Drs. Kachikis, Drake, and Englund reported receiving grants from Merck outside the submitted work. Dr Kachikis reported serving as a research consultant for Pfizer and GlaxoSmithKline on maternal immunization–related projects in 2020 outside the submitted work. Dr Englund reported receiving consulting fees from Sanofi Pasteur, Meissa Vaccines, and AstraZeneca and grants from Pfizer, GlaxoSmithKline, AstraZeneca, Novavax, and Chimerix outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Reactions 1 Day Postvaccination
See this image and copyright information in PMC

References

    1. Pfizer and BioNTech . Pfizer and BioNTech conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting all primary efficacy endpoints. Accessed July 9, 2021. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-an...
    1. Moderna. Moderna announces primary efficacy analysis in phase 3 COVE Study for its COVID-19 Vaccine Candidate and Filing today with U.S. FDA for Emergency Use Authorization. Accessed July 9, 2021. https://investors.modernatx.com/news-releases/news-release-details/moder...
    1. Delahoy MJ, Whitaker M, O’Halloran A, et al. ; COVID-NET Surveillance Team . Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19—COVID-NET, 13 states, March 1-August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38):1347-1354. doi:10.15585/mmwr.mm6938e1 - DOI - PMC - PubMed
    1. American College of Obstetricians and Gynecologists . COVID-19 vaccination considerations for obstetric–gynecologic care: practice advisory. Updated July 2, 2021. Accessed July 13, 2021. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articl...
    1. Centers for Disease Control and Prevention . COVID-19 vaccines while pregnant or breastfeeding. Updated June 29, 2021. Accessed July 13, 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregn...

Publication types

MeSH terms

Substances